Back to search
Chronic Allograft Nephropathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Allograft Nephropathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Allograft Nephropathy trials you may qualify forChronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month k…
The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplan…
This clinical trial investigates the transplantation of donor kidneys that have been genetically modified ex vivo using CRISPR-Cas9 genome editing to reduce imm…
This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.
Post market registry to assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,
Endothelial lesions within the transplanted kidney are a major determinant of chronic allograft nephropathy. Epoxyeicosatrienoic acids (EETs) are endothelium-de…
The investigators have shown that epithelial-to-mesenchymal transition (EMT) markers in early protocol biopsies of the renal allograft predicts the progression…
The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterizati…